Signifor LAR

Recordati Rare Diseases, Inc.🇺🇸 United States

FDA Page

Effective Date: Jan 24, 2024
Approval ID: a0aad470-3f38-af97-e053-2995a90a383a
Products: 5 registered
Version: 16

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SIGNIFOR LAR safely and effectively. See full prescribing information for SIGNIFOR LAR. SIGNIFOR LAR (pasireotide) for injectable suspension, for intramuscular use Initial U.S. Approval: 2012

Quick Stats

Total Products5

Labelers2

Label Sections40

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.